{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:54:42Z","timestamp":1793390082250,"version":"4.5.0"},"reference-count":96,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,9,28]]},"DOI":"10.1001\/jama.2021.8551","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T18:47:58Z","timestamp":1632854878000},"page":"1192","source":"Crossref","is-referenced-by-count":216,"title":["Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality"],"prefix":"10.1001","volume":"326","author":[{"given":"Jillian T.","family":"Henderson","sequence":"first","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly K.","family":"Vesco","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn A.","family":"Senger","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel G.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Redmond","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"jus210013r1","first-page":"1","article-title":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia.","volume":"133","author":"American College of Obstetricians and Gynecologists","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"4","key":"jus210013r2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"9741","key":"jus210013r3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia.","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"jus210013r4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system.","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"jus210013r6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013.","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"jus210013r7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","article-title":"Placental origins of preeclampsia: challenging the current hypothesis.","volume":"51","author":"Huppertz","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"jus210013r8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia.","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"jus210013r9","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6268276","article-title":"Preeclampsia in 2018: revisiting concepts, physiopathology, and prediction.","volume":"2018","author":"Mayrink","year":"2018","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"jus210013r10","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis.","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"6","key":"jus210013r11","doi-asserted-by":"publisher","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease.","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"jus210013r12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ajog.2006.05.021","article-title":"Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth.","volume":"195","author":"Ananth","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"jus210013r14","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1080\/14767058.2019.1581522","article-title":"Preeclampsia outcomes at delivery and race.","volume":"33","author":"Gyamfi-Bannerman","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"10","key":"jus210013r18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force.","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"17","key":"jus210013r21","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Improved tests for a random effects meta-regression with a single covariate.","volume":"22","author":"Knapp","year":"2003","journal-title":"Stat Med"},{"issue":"1","key":"jus210013r22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jrsm.v10.1","article-title":"Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis.","volume":"10","author":"Veroniki","year":"2019","journal-title":"Res Synth Methods"},{"issue":"5","key":"jus210013r23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials.","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"jus210013r24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010983","article-title":"Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study.","volume":"6","author":"Cheng","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"jus210013r25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis.","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"jus210013r26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1536867X0400400204","article-title":"Funnel plots in meta-analysis.","volume":"4","author":"Sterne","year":"2004","journal-title":"Stata J."},{"issue":"2","key":"jus210013r27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/sim.6342","article-title":"Statistical methods for dealing with publication bias in meta-analysis.","volume":"34","author":"Jin","year":"2015","journal-title":"Stat Med"},{"issue":"8471","key":"jus210013r28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.","volume":"1","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"issue":"6","key":"jus210013r29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJM198908103210604","article-title":"Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.","volume":"321","author":"Benigni","year":"1989","journal-title":"N Engl J Med"},{"issue":"6","key":"jus210013r30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies.","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med"},{"issue":"8705","key":"jus210013r31","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/0140-6736(90)91377-M","article-title":"Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension.","volume":"335","author":"McParland","year":"1990","journal-title":"Lancet"},{"issue":"4","key":"jus210013r32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","article-title":"Low-dose aspirin therapy to prevent preeclampsia.","volume":"168","author":"Hauth","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"jus210013r33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women.","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"issue":"9","key":"jus210013r34","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/bjo.1993.100.issue-9","article-title":"Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn.","volume":"100","author":"Viinikka","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"jus210013r35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/aji.1994.31.issue-1","article-title":"Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report.","volume":"31","author":"Caspi","year":"1994","journal-title":"Am J Reprod Immunol"},{"issue":"8898","key":"jus210013r36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women.","volume":"343","author":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"jus210013r37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/10641959509058050","article-title":"Low-dose aspirin in the prevention of hypertensive disorders of pregnancy in relatively low-risk nulliparous women.","volume":"14","author":"Davies","year":"1995","journal-title":"Hypertens Pregnancy."},{"issue":"2","key":"jus210013r38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/10641959709031640","article-title":"Low-dose aspirin in high-risk pregnancy?","volume":"16","author":"Gallery","year":"1997","journal-title":"Hypertens Pregnancy."},{"issue":"3, pt 2","key":"jus210013r39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/01.HYP.30.3.589","article-title":"Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women.","volume":"30","author":"Hermida","year":"1997","journal-title":"Hypertension"},{"issue":"11","key":"jus210013r40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk.","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"jus210013r41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/bjo.1998.105.issue-3","article-title":"Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.","volume":"105","author":"Rotchell","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"jus210013r42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1469-0705.2000.00009.x","article-title":"Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial.","volume":"15","author":"Grab","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"jus210013r43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (part 1).","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"issue":"3","key":"jus210013r44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(ISSN)1469-0705","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks\u2019 gestation.","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1-2","key":"jus210013r45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"issue":"1","key":"jus210013r46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO trial and a meta-analysis of randomised trials.","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"issue":"7","key":"jus210013r47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial.","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open"},{"issue":"7","key":"jus210013r48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia.","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"jus210013r49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/uog.2017.49.issue-4","article-title":"Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14?weeks: a randomized controlled study.","volume":"49","author":"Scazzocchio","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"jus210013r50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0029-7844(95)00340-1","article-title":"A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow.","volume":"87","author":"Morris","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"5","key":"jus210013r51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/17512433.1.5.605","article-title":"Major malformations after first trimester exposure to aspirin and NSAIDs.","volume":"1","author":"Nakhai-Pour","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"jus210013r52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bjo.2003.110.issue-10","article-title":"Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making.","volume":"110","author":"Coomarasamy","year":"2003","journal-title":"BJOG"},{"issue":"3","key":"jus210013r53","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"Nonsteroidal antiinflammatory drug use among women and the risk of birth defects.","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"jus210013r54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/ppe.2017.31.issue-6","article-title":"Gastroschisis in Europe\u2014a case-malformed-control study of medication and maternal illness during pregnancy as risk factors.","volume":"31","author":"Given","year":"2017","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"6","key":"jus210013r55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/EDE.0b013e3181f20bed","article-title":"Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism.","volume":"21","author":"Jensen","year":"2010","journal-title":"Epidemiology"},{"issue":"4","key":"jus210013r56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.ede.0000221693.72971.b3","article-title":"Aspirin use and miscarriage risk.","volume":"17","author":"Keim","year":"2006","journal-title":"Epidemiology"},{"issue":"10","key":"jus210013r57","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications.","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"9575","key":"jus210013r58","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"jus210013r59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046042","article-title":"Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice.","volume":"7","author":"Stewart","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"jus210013r60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis.","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"jus210013r61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/AOG.0000000000001848","article-title":"Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis.","volume":"129","author":"van Vliet","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jus210013r62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajog.2018.03.018","article-title":"Optimal aspirin dosing for preeclampsia prevention.","volume":"219","author":"Seidler","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"jus210013r63","doi-asserted-by":"publisher","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin.","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"jus210013r64","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s40615-019-00619-3","article-title":"Socioeconomic status, preeclampsia risk and gestational length in black and white women.","volume":"6","author":"Ross","year":"2019","journal-title":"J Racial Ethn Health Disparities"},{"issue":"4","key":"jus210013r65","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/10641955.2015.1090581","article-title":"Racial disparities in comorbidities, complications, and maternal and fetal outcomes in women with preeclampsia\/eclampsia.","volume":"34","author":"Shahul","year":"2015","journal-title":"Hypertens Pregnancy"},{"issue":"35","key":"jus210013r66","doi-asserted-by":"publisher","first-page":"762","DOI":"10.15585\/mmwr.mm6835a3","article-title":"Racial\/ethnic disparities in pregnancy-related deaths\u2014United States, 2007-2016.","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"jus210013r67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/GRF.0000000000000349","article-title":"Reducing disparities in severe maternal morbidity and mortality.","volume":"61","author":"Howell","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"jus210013r68","doi-asserted-by":"publisher","first-page":"365.e1","DOI":"10.1016\/j.ajog.2017.04.035","article-title":"Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia.","volume":"217","author":"Tolcher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"jus210013r69","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/bjo.1995.102.issue-11","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy.","volume":"102","author":"Clasp Collaborative Group","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"jus210013r70","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.110.941203","article-title":"Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia.","volume":"122","author":"Jayet","year":"2010","journal-title":"Circulation"},{"key":"jus210013r71","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.preghy.2018.06.013","article-title":"Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring.","volume":"13","author":"Nahum Sacks","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"jus210013r72","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/acps.v142.4","article-title":"Association between preeclampsia and attention-deficit hyperactivity disorder: a population-based and sibling-matched cohort study.","volume":"142","author":"Maher","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"jus210013r73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.earlhumdev.2019.01.016","article-title":"Long-term neuropsychiatric morbidity in children exposed prenatally to preeclampsia.","volume":"130","author":"Nahum Sacks","year":"2019","journal-title":"Early Hum Dev"},{"issue":"8","key":"jus210013r74","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jamapsychiatry.2020.0306","article-title":"Association of preeclampsia in term births with neurodevelopmental disorders in offspring.","volume":"77","author":"Sun","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"jus210013r75","doi-asserted-by":"publisher","first-page":"e1552","DOI":"10.1542\/peds.2011-3093","article-title":"Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review.","volume":"129","author":"Davis","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"jus210013r76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/clc.21965","article-title":"Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.","volume":"35","author":"Valdiviezo","year":"2012","journal-title":"Clin Cardiol"},{"issue":"7627","key":"jus210013r77","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"issue":"6","key":"jus210013r78","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/HYPERTENSIONAHA.109.130765","article-title":"Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother.","volume":"53","author":"Lykke","year":"2009","journal-title":"Hypertension"},{"key":"jus210013r79","doi-asserted-by":"crossref","first-page":"A174","DOI":"10.1161\/str.49.suppl_1.174","article-title":"Preeclampsia and early stroke incidence in the California Teachers Study.","volume":"49","author":"Miller","year":"2018","journal-title":"Stroke"},{"issue":"6","key":"jus210013r80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104720","article-title":"Tracking the development of cerebrovascular risk factors following pregnancy with preeclampsia.","volume":"29","author":"Lederer","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"jus210013r81","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11906-019-0977-0","article-title":"Investigating maternal brain alterations in preeclampsia: the need for a multidisciplinary effort.","volume":"21","author":"Bergman","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"jus210013r82","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"jus210013r83","first-page":"283","article-title":"Racial\/ethnic differences in pregnancy-related hypertensive disease in nulliparous women.","volume":"24","author":"Ghosh","year":"2014","journal-title":"Ethn Dis"},{"issue":"11","key":"jus210013r84","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"jus210013r85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14767058.2020.1745181","article-title":"High-altitude residence alters blood-pressure course and increases hypertensive disorders of pregnancy.","author":"Bailey","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"jus210013r86","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy.","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"key":"jus210013r87","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.109471","article-title":"Association between ambient air pollution and pregnancy complications: a systematic review and meta-analysis of cohort studies.","volume":"185","author":"Bai","year":"2020","journal-title":"Environ Res"},{"issue":"2","key":"jus210013r88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229568","article-title":"The presence of coexisting sleep-disordered breathing among women with hypertensive disorders of pregnancy does not worsen perinatal outcome.","volume":"15","author":"Wilson","year":"2020","journal-title":"PLoS One"},{"key":"jus210013r89","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fneur.2018.00091","article-title":"Association between sleep-disordered breathing during pregnancy and maternal and fetal outcomes: an updated systematic review and meta-analysis.","volume":"9","author":"Li","year":"2018","journal-title":"Front Neurol"},{"issue":"12","key":"jus210013r90","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/OGX.0000000000000738","article-title":"Associations between migraine and adverse pregnancy outcomes: systematic review and meta-analysis.","volume":"74","author":"Aukes","year":"2019","journal-title":"Obstet Gynecol Surv"},{"issue":"9","key":"jus210013r91","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/1471-0528.14029","article-title":"The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.","volume":"123","author":"Al-Rubaie","year":"2016","journal-title":"BJOG"},{"issue":"6","key":"jus210013r92","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"jus210013r93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers.","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"jus210013r94","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejogrb.2017.08.031","article-title":"External validation of preexisting first trimester preeclampsia prediction models.","volume":"217","author":"Allen","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"16","key":"jus210013r95","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jama.2016.18315","article-title":"Preeclampsia screening: evidence report and systematic review for the US Preventive Services Task Force.","volume":"317","author":"Henderson","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"jus210013r96","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrneph.2017.121","article-title":"Pre-eclampsia: screening and aspirin therapy for prevention of pre-eclampsia.","volume":"13","author":"Roberts","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"jus210013r13","volume-title":"Delivery Hospitalizations Involving Preeclampsia and Eclampsia, 2005\u20132014","author":"Fingar","year":"2017"},{"key":"jus210013r16","volume-title":"USPSTF Procedure Manual","author":"US Preventive Services Task Force","year":"2015"},{"key":"jus210013r17","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.8551","volume-title":"Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: An Evidence Update for the US Preventive Services Task Force. Evidence Synthesis No. 205","author":"Henderson","year":"2021"},{"key":"jus210013r19","volume-title":"Human Development Report.","author":"United Nations Development Programme","year":"2016"},{"key":"jus210013r20","first-page":"296","volume-title":"The Handbook of Research Synthesis and Meta-analysis","author":"Raudenbush","year":"2009","edition":"2nd ed"},{"key":"jus210013r5","unstructured":"Pregnancy Mortality Surveillance System: causes of pregnancy-related death in the United States: 2011-2016. Centers for Disease Control and Prevention. Published 2019. Accessed July 15, 2021. https:\/\/www.cdc.gov\/reproductivehealth\/maternal-mortality\/pregnancy-mortality-surveillance-system.htm"},{"key":"jus210013r15","unstructured":"US Preventive Services Task Force. Final recommendation statement: low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: preventive medication. Agency for Health Care Research and Quality. Published 2014. Accessed May 14, 2021. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2784500\/jama_henderson_2021_us_210013_1631920925.02553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T16:50:27Z","timestamp":1699548627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784500"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,9,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.8551","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}